Cargando…
The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
BACKGROUND: In 2007, the priority review voucher (PRV) was implemented in the US to incentivize research and development (R&D) for tropical diseases. The PRV is issued by the US FDA and grants a quicker review to manufacturers upon successful development of a product for a disease eligible for t...
Autores principales: | Aerts, Celine, Barrenho, Eliana, Miraldo, Marisa, Sicuri, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217899/ https://www.ncbi.nlm.nih.gov/pubmed/35588350 http://dx.doi.org/10.1007/s40290-022-00427-x |
Ejemplares similares
-
Correction to: The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
por: Aerts, Celine, et al.
Publicado: (2022) -
Is the priority review voucher program stimulating new drug development for tropical diseases?
por: Kerr, Kirk W., et al.
Publicado: (2018) -
The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products
por: Berman, Jonathan, et al.
Publicado: (2017) -
Priorities for the Priority Review Voucher
por: Ridley, David B.
Publicado: (2017) -
Vertical and horizontal equity of funding for malaria control: a global multisource funding analysis for 2006–2010
por: Barrenho, Eliana, et al.
Publicado: (2017)